These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1139 related items for PubMed ID: 19762681

  • 1. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
    Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, Pedrazzini T, Berger CT, Dirnhofer S, Matter CM, Penninger JM, Lüscher TF, Eriksson U.
    Circ Res; 2009 Oct 23; 105(9):912-20. PubMed ID: 19762681
    [Abstract] [Full Text] [Related]

  • 2. MyD88 signaling controls autoimmune myocarditis induction.
    Marty RR, Dirnhofer S, Mauermann N, Schweikert S, Akira S, Hunziker L, Penninger JM, Eriksson U.
    Circulation; 2006 Jan 17; 113(2):258-65. PubMed ID: 16401773
    [Abstract] [Full Text] [Related]

  • 3. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis.
    Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, Hunziker L, Matter CM, Eriksson U.
    Circ Res; 2009 Aug 28; 105(5):462-70. PubMed ID: 19628793
    [Abstract] [Full Text] [Related]

  • 4. Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis.
    Pagni PP, Traub S, Demaria O, Chasson L, Alexopoulou L.
    Autoimmunity; 2010 Jun 28; 43(4):275-87. PubMed ID: 20187710
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.
    Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, Zheng D, Gabrielson K, Iwakura Y, Rose NR, Cihakova D.
    Circ Res; 2010 May 28; 106(10):1646-55. PubMed ID: 20378858
    [Abstract] [Full Text] [Related]

  • 6. Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis.
    Kania G, Blyszczuk P, Valaperti A, Dieterle T, Leimenstoll B, Dirnhofer S, Zulewski H, Eriksson U.
    Cardiovasc Res; 2008 Nov 01; 80(2):236-45. PubMed ID: 18621802
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of cardiac fibrosis in inflammatory heart disease.
    Kania G, Blyszczuk P, Eriksson U.
    Trends Cardiovasc Med; 2009 Nov 01; 19(8):247-52. PubMed ID: 20447565
    [Abstract] [Full Text] [Related]

  • 8. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
    Fuse K, Chan G, Liu Y, Gudgeon P, Husain M, Chen M, Yeh WC, Akira S, Liu PP.
    Circulation; 2005 Oct 11; 112(15):2276-85. PubMed ID: 16216974
    [Abstract] [Full Text] [Related]

  • 9. Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis.
    Kania G, Siegert S, Behnke S, Prados-Rosales R, Casadevall A, Lüscher TF, Luther SA, Kopf M, Eriksson U, Blyszczuk P.
    Circulation; 2013 Jun 11; 127(23):2285-94. PubMed ID: 23671208
    [Abstract] [Full Text] [Related]

  • 10. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity.
    Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM.
    Nat Med; 2003 Dec 11; 9(12):1484-90. PubMed ID: 14625544
    [Abstract] [Full Text] [Related]

  • 11. Dendritic cells and autoimmune heart failure.
    Marty RR, Eriksson U.
    Int J Cardiol; 2006 Sep 10; 112(1):34-9. PubMed ID: 16891018
    [Abstract] [Full Text] [Related]

  • 12. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis.
    Cruz-Adalia A, Jiménez-Borreguero LJ, Ramírez-Huesca M, Chico-Calero I, Barreiro O, López-Conesa E, Fresno M, Sánchez-Madrid F, Martín P.
    Circulation; 2010 Oct 05; 122(14):1396-404. PubMed ID: 20855659
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
    Wang Z, Liao Y, Dong J, Li S, Wang J, Fu ML.
    Chin Med J (Engl); 2003 Apr 05; 116(4):499-502. PubMed ID: 12875710
    [Abstract] [Full Text] [Related]

  • 14. GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis.
    Blyszczuk P, Behnke S, Lüscher TF, Eriksson U, Kania G.
    Biochim Biophys Acta; 2013 Apr 05; 1833(4):934-44. PubMed ID: 23103516
    [Abstract] [Full Text] [Related]

  • 15. Involvement of Sema4A in the progression of experimental autoimmune myocarditis.
    Makino N, Toyofuku T, Takegahara N, Takamatsu H, Okuno T, Nakagawa Y, Kang S, Nojima S, Hori M, Kikutani H, Kumanogoh A.
    FEBS Lett; 2008 Nov 26; 582(28):3935-40. PubMed ID: 18977352
    [Abstract] [Full Text] [Related]

  • 16. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17.
    Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U.
    J Exp Med; 2006 Aug 07; 203(8):2009-19. PubMed ID: 16880257
    [Abstract] [Full Text] [Related]

  • 17. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice.
    Gangaplara A, Massilamany C, Brown DM, Delhon G, Pattnaik AK, Chapman N, Rose N, Steffen D, Reddy J.
    Clin Immunol; 2012 Sep 07; 144(3):237-49. PubMed ID: 22854287
    [Abstract] [Full Text] [Related]

  • 18. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L.
    Brain; 2012 May 07; 135(Pt 5):1586-605. PubMed ID: 22447120
    [Abstract] [Full Text] [Related]

  • 19. Alterations in cardiac function and gene expression during autoimmune myocarditis in mice.
    Stull LB, DiIulio NA, Yu M, McTiernan CF, Ratliff NB, Tuohy VK, Moravec CS.
    J Mol Cell Cardiol; 2000 Nov 07; 32(11):2035-49. PubMed ID: 11040107
    [Abstract] [Full Text] [Related]

  • 20. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
    Martín R, Cordova C, San Román JA, Gutierrez B, Cachofeiro V, Nieto ML.
    J Mol Cell Cardiol; 2014 Jul 07; 72():250-62. PubMed ID: 24732212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.